M J O'Connell

3.0k total citations
46 papers, 2.2k citations indexed

About

M J O'Connell is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, M J O'Connell has authored 46 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 14 papers in Pathology and Forensic Medicine. Recurrent topics in M J O'Connell's work include Colorectal Cancer Treatments and Studies (21 papers), Gastric Cancer Management and Outcomes (13 papers) and Cancer Treatment and Pharmacology (10 papers). M J O'Connell is often cited by papers focused on Colorectal Cancer Treatments and Studies (21 papers), Gastric Cancer Management and Outcomes (13 papers) and Cancer Treatment and Pharmacology (10 papers). M J O'Connell collaborates with scholars based in United States, Ireland and France. M J O'Connell's co-authors include Harry S. Wieand, James E. Krook, C G Moertel, J A Mailliard, Greg Yothers, Peter A. Cassileth, Norman Wolmark, Richard S. Neiman, Saima Sharif and Carmen J. Allegra and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

M J O'Connell

46 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M J O'Connell United States 22 1.4k 571 567 450 382 46 2.2k
B. Audhuy France 20 986 0.7× 492 0.9× 316 0.6× 432 1.0× 150 0.4× 48 1.9k
P. Fargeot France 30 1.7k 1.2× 326 0.6× 575 1.0× 162 0.4× 564 1.5× 87 2.7k
Paolo G. Gobbi Italy 29 905 0.6× 1.6k 2.8× 497 0.9× 435 1.0× 326 0.9× 86 2.6k
Dae Young Zang South Korea 27 1.1k 0.8× 206 0.4× 1.3k 2.2× 457 1.0× 593 1.6× 184 2.6k
Stephen Shibata United States 28 1.2k 0.8× 189 0.3× 601 1.1× 275 0.6× 545 1.4× 84 2.2k
A.J. Dembo Canada 29 530 0.4× 458 0.8× 467 0.8× 214 0.5× 1.1k 2.9× 53 2.8k
James S. Hewlett United States 23 668 0.5× 282 0.5× 224 0.4× 812 1.8× 178 0.5× 53 1.8k
Syma Iqbal United States 29 2.0k 1.4× 539 0.9× 993 1.8× 169 0.4× 679 1.8× 129 3.1k
Michael Emig Germany 17 2.1k 1.5× 327 0.6× 2.5k 4.5× 473 1.1× 786 2.1× 46 4.0k
Edoardo Ascari Italy 25 566 0.4× 494 0.9× 337 0.6× 623 1.4× 171 0.4× 96 2.2k

Countries citing papers authored by M J O'Connell

Since Specialization
Citations

This map shows the geographic impact of M J O'Connell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M J O'Connell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M J O'Connell more than expected).

Fields of papers citing papers by M J O'Connell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M J O'Connell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M J O'Connell. The network helps show where M J O'Connell may publish in the future.

Co-authorship network of co-authors of M J O'Connell

This figure shows the co-authorship network connecting the top 25 collaborators of M J O'Connell. A scholar is included among the top collaborators of M J O'Connell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M J O'Connell. M J O'Connell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O'Connell, M J, et al.. (2010). The Clean Heat Project: Improving Air Quality and Energy Efficiency Outcomes for the Canterbury Region. 44(2). 28. 4 indexed citations
2.
Wolmark, Norman, Greg Yothers, M J O'Connell, et al.. (2009). A phase III trial comparing mFOLFOX6 to mFOLFOX6 plus bevacizumab in stage II or III carcinoma of the colon: Results of NSABP Protocol C-08. Journal of Clinical Oncology. 27(18_suppl). LBA4–LBA4. 47 indexed citations
3.
Wolmark, Norman, Greg Yothers, M J O'Connell, et al.. (2009). A phase III trial comparing mFOLFOX6 to mFOLFOX6 plus bevacizumab in stage II or III carcinoma of the colon: Results of NSABP Protocol C-08. Journal of Clinical Oncology. 27(15_suppl). LBA4–LBA4. 102 indexed citations
4.
5.
Kim, Kyung‐Min, MM Oken, Louis Letendre, et al.. (2000). Low-dose cytarabine maintenance therapy vs observation after remission induction in advanced acute myeloid leukemia: an Eastern Cooperative Oncology Group Trial (E5483). Leukemia. 14(8). 1349–1353. 25 indexed citations
6.
7.
Wiesenfeld, Martin, M J O'Connell, Harry S. Wieand, et al.. (1995). Controlled clinical trial of interferon-gamma as postoperative surgical adjuvant therapy for colon cancer.. Journal of Clinical Oncology. 13(9). 2324–2329. 53 indexed citations
8.
Cullinan, Stephen A., C G Moertel, Harry S. Wieand, et al.. (1994). Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group.. Journal of Clinical Oncology. 12(2). 412–416. 114 indexed citations
9.
Buroker, T, M J O'Connell, Harry S. Wieand, et al.. (1994). Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer.. Journal of Clinical Oncology. 12(1). 14–20. 248 indexed citations
10.
Miller, K B, Francis S. Morrison, Jane N. Winter, et al.. (1993). The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study. Annals of Hematology. 66(3). 164–164. 91 indexed citations
11.
Höchster, Howard S., R B Mann, Richard S. Neiman, et al.. (1992). Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study.. Journal of Clinical Oncology. 10(1). 28–32. 139 indexed citations
12.
Cassileth, Peter A., Janet W. Andersen, John M. Bennett, et al.. (1992). Escalating the intensity of postremission therapy improves the outcome in acute myeloid leukemia: The ECOG experience. 6. 116–119. 14 indexed citations
13.
Miller, K B, Francis S. Morrison, Jane N. Winter, et al.. (1992). The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: A phase-III intergroup study. Annals of Hematology. 65(4). 162–168. 83 indexed citations
14.
O'Connell, M J, et al.. (1989). Active specific immunotherapy with antiidiotypic antibodies in patients with solid tumors. Seminars in Surgical Oncology. 5(6). 441–447. 14 indexed citations
15.
16.
O'Connell, M J, Donald P. Harrington, John D. Earle, et al.. (1987). Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma.. Journal of Clinical Oncology. 5(9). 1329–1339. 14 indexed citations
17.
O'Connell, M J, Joseph P. Colgan, Martin M. Oken, et al.. (1986). Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group pilot study.. Journal of Clinical Oncology. 4(2). 128–136. 95 indexed citations
18.
Moertel, C G, et al.. (1984). Evaluation of combined cyclophosphamide and methotrexate therapy in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome.. PubMed. 68(4). 665–7. 14 indexed citations
19.
O'Connell, M J, C G Moertel, Joseph Rubin, et al.. (1984). Clinical trial of sequential N-phosphonacetyl-L-aspartate, thymidine, and 5-fluorouracil in advanced colorectal carcinoma.. Journal of Clinical Oncology. 2(10). 1133–1138. 9 indexed citations
20.
O'Connell, M J & P H Wiernik. (1972). Remissions of Metastatic Testicular Cancer. New England Journal of Medicine. 287(19). 989–989. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Audhuy Breakdown of academic impact, for papers by P. Fargeot Breakdown of academic impact, for papers by Paolo G. Gobbi Breakdown of academic impact, for papers by Dae Young Zang Breakdown of academic impact, for papers by Stephen Shibata Breakdown of academic impact, for papers by A.J. Dembo Breakdown of academic impact, for papers by James S. Hewlett Breakdown of academic impact, for papers by Syma Iqbal Breakdown of academic impact, for papers by Michael Emig Breakdown of academic impact, for papers by Edoardo Ascari
Rankless by CCL
2026